Understanding Bowel Cancer Family History: Key Risk Factors and Early Screening Explained
Learn how family history affects your bowel cancer risk, including Lynch syndrome and FAP, and when to think about screening early.

Bowel cancer family history is one of the strongest known risk factors for developing bowel cancer, especially when a first-degree relative, a parent, sibling or child, has been diagnosed. Around 20 to 30 per cent of bowel cancer cases involve a family history, and a smaller share are linked to inherited conditions such as Lynch syndrome and familial adenomatous polyposis (FAP) (Bowel Cancer Australia, 2024; National Cancer Institute, 2025). If you have a family history, Everlab will help you to understand your personal risk and screening timeline.
A first-degree relative is a parent, sibling or child. A second-degree relative is a grandparent, aunt, uncle, niece, nephew or half-sibling. Clinicians look at both when assessing family history, but a first-degree relative diagnosis generally carries more weight (Bowel Cancer Australia, 2024).
A pattern is often described as a significant family history when it includes more than one affected relative, a diagnosis before age 55, or bowel cancer and polyps appearing across more than one generation. Any of these patterns is a reason to talk to your GP about earlier or more frequent screening.
Having one first-degree relative diagnosed with bowel cancer roughly doubles your risk of developing bowel cancer compared with the general population. Your risk increases further if more than one relative has been diagnosed, a relative was diagnosed young, or an inherited genetic condition runs in the family.
This link has been studied for decades. One of the earliest large prospective studies to establish family history as an independent risk factor followed thousands of participants over time and found a clear association between family history and colorectal cancer risk (Fuchs et al., New England Journal of Medicine, 1994). A separate population-based study reached similar conclusions using data from the Utah Population Database (Slattery & Kerber, Journal of the National Cancer Institute, 1994). Studies suggest the pattern holds regardless of which side of the family is affected (Jenkins et al., Medical Journal of Australia, 2018).
Family history is one of several known risk factors for bowel cancer. Awareness of the different risk factors helps put any single result, including a family history, into proper context (Cancer Council Australia, 2023).
People with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, face an increased risk of developing bowel cancer over time, and that risk rises with the duration and extent of the disease. One meta-analysis estimated the cumulative risk of colorectal cancer in ulcerative colitis at around 2 per cent at 10 years, 8 per cent at 20 years and 18 per cent at 30 years of disease (Eaden et al., Gut, 2001). Crohn's disease affecting the colon has been associated with a similarly elevated risk (Canavan et al., Alimentary Pharmacology & Therapeutics, 2006).
A personal history of bowel cancer or adenomatous polyps (small growths called adenomas) also raises colorectal cancer risk, as does previous radiation therapy to the abdomen or pelvis.
Several modifiable, lifestyle-related risk factors for bowel cancer sit alongside family history and personal history:
None of these factors guarantee bowel cancer will or will not develop. They combine with family history and personal history to shape your overall risk profile.
A smaller number of bowel cancer cases are linked to specific hereditary conditions rather than family history and lifestyle alone. The U.S. National Cancer Institute estimates that inherited high-risk gene changes, across all known syndromes combined, account for around 5 to 6 per cent of colorectal cancer cases overall (National Cancer Institute, 2025).
Familial adenomatous polyposis (FAP) is caused by changes in the APC gene and is responsible for less than 1 per cent of all bowel cancer cases (Journal of Medical Genetics, 1999). It is one of several rare inherited conditions in which hundreds or thousands of polyps develop in the colon and rectum, often from the teenage years. Left unmanaged, most people with FAP will go on to develop colorectal cancer, usually at a younger age than the general population.
A related, recessively inherited condition called MUTYH-associated polyposis (MAP) causes a similar pattern of multiple colon polyps. It is caused by a gene fault in the MUTYH gene rather than APC, and is generally identified through the same genetic testing pathway used to investigate suspected FAP.
Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common inherited syndrome linked to bowel cancer, accounting for an estimated 2 to 5 per cent of colorectal cancer cases (Centers for Disease Control and Prevention, 2026). It is caused by an inherited gene fault in one of the DNA mismatch repair (MMR) genes, MLH1, MSH2, MSH6 or PMS2, or in the EPCAM gene, which disrupts the nearby MSH2 gene (American Cancer Society, cancer.org).
People with Lynch syndrome face a higher lifetime chance of developing cancer, and not only in the bowel. Other cancers associated with Lynch syndrome include ovarian cancer, endometrial cancer, stomach cancer, urinary tract cancer, and a modestly increased risk of prostate cancer and pancreatic cancer (American Cancer Society, cancer.org). These gene changes can be passed from a parent to a child, which is why a diagnosis in one relative often prompts genetic counselling for others. Read more in our dedicated guide to Lynch syndrome.
Bowel cancer is most common in Australians aged 75 and over, but rates in younger adults have been rising, and around 1 in 9 cases are now diagnosed in Australians under 50 (Bowel Cancer Australia, 2024). Family history and inherited factors help explain why some people are affected at a younger age than the average age of diagnosis, which is why screening guidelines base the starting age on family history rather than age alone.
Observing symptoms such as persistent changes in bowel habits, blood in the stool, unexplained weight loss or abdominal pain necessitates immediate consultation with a GP, whether or not you have a family history. Screening is designed to catch changes before symptoms appear, but new symptoms should never wait for a scheduled screening date.
The Cancer Council Australia Clinical Practice Guidelines, approved by the NHMRC in 2023, place people into three risk categories based on family history (Cancer Council Australia, 2023; Jenkins et al., Medical Journal of Australia, 2018):
Each category carries a different recommended screening test, starting age and interval. Your GP is best placed to confirm which category applies to you.
How this compares internationally: screening ages and intervals differ by country. In the United States, the American College of Gastroenterology advises that people with one first-degree relative diagnosed before 60, or two first-degree relatives diagnosed at any age, start colonoscopy at 40 or 10 years younger than the youngest affected relative, whichever comes first, repeated every five years (American College of Gastroenterology guideline, summarised in American Family Physician, 2022). The American Cancer Society's average-risk guidance starts screening at 45 (American Cancer Society, cancer.org). Australian readers should follow Cancer Council Australia's guidelines and their own GP's advice, since the recommended ages and intervals are not identical between countries.
If a hereditary cancer syndrome such as Lynch syndrome or FAP is suspected, based on multiple affected relatives, early ages at diagnosis, or other cancers running in the family, your GP can refer you for genetic testing and genetic counselling. Testing looks for the specific gene fault involved, which helps clarify risk not just for you but for other family members who may also carry it. Everlab's genetic testing page explains how this type of testing generally works.
You cannot change your family history, but several other risk factors are within your influence. Maintaining a healthy body weight and managing BMI are crucial in reducing bowel cancer risk, alongside regular physical activity, adequate fibre intake, limiting red and processed meat, moderating alcohol, and not smoking.
Sharing family history details with other family members also matters. Many Australians do not know the specifics of cancer diagnoses in their own family, including who was affected and at what age, and that detail directly affects which screening category applies. Our guide on how to reduce bowel cancer risk covers these modifiable factors in more depth.
Yes. Around 20 to 30 per cent of bowel cancer cases involve a family history, and having a first-degree relative diagnosed roughly doubles your own risk compared with the general population (Bowel Cancer Australia, 2024).
Familial adenomatous polyposis (FAP) is caused by changes in the APC gene and causes hundreds to thousands of colon polyps, accounting for less than 1 per cent of bowel cancer cases. Lynch syndrome is caused by a fault in a DNA mismatch repair gene or the EPCAM gene, does not typically cause large numbers of polyps, and accounts for an estimated 2 to 5 per cent of colorectal cancer cases (Centers for Disease Control and Prevention, 2026).
Bowel cancer risk can be reduced and managed, through screening, healthy body weight, physical activity and limiting known lifestyle risk factors, but no test or lifestyle change can guarantee prevention. Screening aims to find risk indicators and early changes before symptoms appear.
It depends on the risk category your family history places you in. Your GP will confirm this using Cancer Council Australia's guidelines, and screening for higher-risk categories generally starts younger and more frequently than the general population schedule.
Persistent changes in bowel habits, blood in the stool, unexplained weight loss or abdominal pain should prompt an immediate GP visit, regardless of your age or family history.
If you have a family history of bowel cancer, the most useful next step is a conversation with your GP about which relatives were affected and at what age, whether your family history places you in a higher-risk screening category, whether genetic counselling is appropriate, and how often you should be screened.
Everlab's health assessments look at biomarkers across a number of major chronic condition categories over time, and can support the conversation about your personal risk profile.
Disclaimer: This article is for informational purposes only and does not constitute medical advice.

Join 1000's of Australians improving their health with proactive, personalised healthcare.